Abstract
Even the most recent of several commendable articles in The BMJ on epilepsy and valproate during pregnancy missed that regulatory agencies should have acted earlier.1 The first report of malformations due to valproate was in 1982.2 Despite many meetings and reports, no action was taken until 2015, when a legal case went public, thanks to a mother whose two children, one after the other, were damaged. She also …